Hyperfine Inc. is a leading medical technology innovator that has revolutionized imaging diagnostics with the introduction of the first FDA-cleared portable MRI system. This groundbreaking solution enhances accessibility to imaging directly at the point of care, thereby improving patient outcomes and expediting clinical decision-making. By prioritizing cost efficiency and convenience, Hyperfine is well-positioned to capitalize on burgeoning market opportunities, making it an appealing investment for institutional investors interested in transformative healthcare advancements.
| Revenue (TTM) | $15.33M |
| Gross Profit (TTM) | $7.85M |
| EBITDA | $-33.61M |
| Operating Margin | -219.30% |
| Return on Equity | -89.80% |
| Return on Assets | -38.20% |
| Revenue/Share (TTM) | $0.18 |
| Book Value | $0.35 |
| Price-to-Book | 3.79 |
| Price-to-Sales (TTM) | 7.90 |
| EV/Revenue | 6.69 |
| EV/EBITDA | -0.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 82.60% |
| Shares Outstanding | $84.22M |
| Float | $79.64M |
| % Insiders | 4.81% |
| % Institutions | 14.67% |
Volatility is currently expanding
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine initiates the launch of the next-gen Swoop® system in Europe, beginning global expansion of its most advanced portable MRI technology. .
GUILFORD, Conn.--(BUSINESS WIRE)--Leading neurosurgeons will help guide the role of the Swoop® system in neurosurgical care, including workflow, product capabilities, and evidence.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces Swoop® system scan volume milestones at key hospitals and neurology clinics, demonstrating accelerating adoption across the US.
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings.
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2026 financial results and provided a business update. “Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to present at the upcoming 2026 Jefferies Global Healthcare Conference on Thursday, June 4th at 8:45 am Eastern Time (ET). A live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.'s c.
NEW DELHI--(BUSINESS WIRE)--AIIMS New Delhi has begun clinical use of the Swoop® system, becoming the first hospital in India to deploy bedside MRI.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine to report financial results for Q1 2026 on Tue., May 12, 2026. Management will host corresponding conference call at 1:30 PM PT/4:30 PM ET.
